Investor Relations

Economic success ensures medical quality. We pay particular attention to the ability to invest in our existing medical facilities at any time. We are also financially prepared for external growth and can react quickly.

Bild: PioNear - Asklepios Annual Report 2022
© Asklepios

Annual Report 2022

What will the future of medicine be like? How do we manage to be an innovation driver while also staying close to people? With exciting stories and interesting facts, we offer an insight into the past financial year and Asklepios's strategy.

Learn more
Bild: PioNear - Asklepios Corporate Responsibility Report 2022
© Asklepios

Corporate Responsibility Report 2022

As a leading healthcare group, we not only take responsibility for our patients but also for employees, the enviroment, and society. Here you can read about what we have already achieved and what we have undertaken for the future.

Learn more

Latest documents at a glance

IR-News

Portraitfoto von Asklepios-Gründer Dr. Bernard große Broermann mit Lebensdaten

27.02.2024Asklepios mourns its founder and shareholder Dr. Bernard große Broermann

23.11.2023Asklepios Group: Sound business performance in first nine months of 2023

24.08.2023Asklepios Group: Stable development in H1 2023 despite challenging market environment

25.05.2023Asklepios Group: Resilient business performance in Q1 2023

All notifications

Further Information

Financial reports

Asklepios publishes frequently news and reports about its business and financial development.

Read more

Promissory note loans

Learn more about the key data of our promissory note loans.

Read more

Talk to us

Mirjam Constantin

Mirjam Constantin

Head of Group Reporting (Financial & ESG) | Manager Investor Relations

Share this page